Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

H. J. Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-3039-8463; OpenAlex author ID A5100378741. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 3 papers

Papers 4

  1. Targeting CA9 restricts pancreatic cancer progression through pH regulation and ROS production. Co-author DOI 10.1007/s13402-024-01022-9↗
  2. Identification of PSMD2 as a promising biomarker for pancreatic cancer patients based on comprehensive bioinformatics and in vitro studies. Co-author DOI 10.1016/j.heliyon.2024.e40117↗
  3. NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy. First author DOI 10.1038/s41419-024-06984-0↗
  4. Isolation of circulating tumor cells in pancreatic cancer patients by immunocytochemical assay. Co-author DOI 10.1002/jcla.22156↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuhui Tong · 2 shared papers, 2024 · strength 0.47
  2. Si Shi · 2 shared papers, 2024 · strength 0.47
  3. Xiuxue Feng · 1 shared paper, 2024 · strength 0.28
  4. Enqiang Linghu · 1 shared paper, 2024 · strength 0.28
  5. Jin Xu · 1 shared paper, 2024 · strength 0.26
  6. Wei J. Wang · 1 shared paper, 2024 · strength 0.26
  7. Xianjun Yu · 1 shared paper, 2024 · strength 0.26
  8. Xiaoqi Mao · 1 shared paper, 2024 · strength 0.21
  9. Xianjun Yu · 1 shared paper, 2024 · strength 0.21
  10. Mingwei Dong · 1 shared paper, 2024 · strength 0.21
  11. Yalan Lei · 1 shared paper, 2024 · strength 0.21
  12. Mingming Xiao · 1 shared paper, 2024 · strength 0.21
  13. Bin Zhao · 1 shared paper, 2018 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.